financial guidance
Sophia Genetics Q4, FY24 Revenues Rise 4 Percent on Analysis Growth, New Customers
The firm performed 352,000 analyses with its Sophia DDM platform and signed 92 customers in 2024, including 34 new users of its MSK ACCESS liquid biopsy application.
Natera Q4, Full-Year Revenues Soar on Product Revenue Gains
Natera processed approximately 792,800 tests in the fourth quarter of 2024 compared to 626,800 tests in Q4 2023.
Personalis Q4 Revenues Fall 15 Percent as Full-Year Revenues Jump on Molecular Test Sales
The company's full-year 2024 revenues jumped 15 percent as dwindling contract revenues were buoyed by an uptick in molecular testing sales.
CareDx Q4 Revenues Grow 32 Percent on Strong Testing Services
The company beat analyst estimates on the top and bottom lines for both the fourth quarter and full-year 2024.
Pro forma revenues, including revenues from SomaLogic, which the firm acquired last January, were also down 9 percent.
Feb 26, 2025
MDxHealth Q4 Revenues Rise 28 Percent
Feb 6, 2025
Labcorp Q4 Revenues Rise 10 Percent
Feb 3, 2025
360Dx Top 30 Rockets 10 Percent in January
Jan 30, 2025
Jan 30, 2025
Jan 30, 2025
Roche Diagnostics 2024 Revenues Down 1 Percent
Nov 12, 2024
Natera Q3 Revenues Grow 64 Percent
Nov 12, 2024